Search

everythingexperts & clinicslearnresearchcommunity

for

Search:↓

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Sacituzumab Govitecan is effective for certain breast cancers but requires careful management of side effects.

Many young women with breast cancer experience poor quality of life, especially in sexual health and hair loss, but future outlook improves over time.

Most patients treated with trastuzumab and paclitaxel experience some hair loss, but it's usually not severe.

HER2-targeted or hormonal therapies improve quality of life for Sudanese breast cancer patients.

Minoxidil and ranolazine together can reduce the spread of certain breast cancer cells.

Research from 2011 to 2020 shows androgen receptors could be key for prognosis and treatment in certain breast cancers.

Proactive monitoring and management are essential to maximize the benefits of Trastuzumab Deruxtecan while minimizing serious side effects.

Trastuzumab deruxtecan is effective for HER2-positive breast cancer but requires careful management of side effects.

Abemaciclib can cause skin, hair, and nail problems, leading some patients to stop using it.

The FDA approved a new breast cancer treatment, found flu shots may reduce heart risks, questioned the safety of fast-tracked drug approvals, showed statins don't help with certain pneumonia, and approved a new dementia imaging agent.

Online classes worsened students' emotional state, but returning to full-time classes made it worse.

Dormant melanoma cells in mice interact minimally with memory T cells due to a suppressive tumor environment.

Trodelvy™ helped some patients with advanced breast cancer, but had side effects.

Cold Atmospheric Plasma shows promise in treating aggressive breast cancer by targeting cancer cells while sparing normal tissue.

Severe hair loss significantly worsens quality of life.

New treatments for non-small cell lung cancer are being tested, with some already in use, focusing on immune response and targeting cancer cells, but side effects vary.

Vepdegestrant may become the first FDA-approved PROTAC degrader, marking a new era in drug development.

Low Vitamin D receptor levels in breast cancer are linked to worse outcomes and more bone metastases, and could be a marker for prognosis.

Age and diabetes are linked to larger trichilemmal cysts, while hypertension is linked to smaller ones.

Disitamab vedotin and gemcitabine effectively treated bladder cancer without major side effects.

Breast cancer treatments work better with AR activation, improving results and reducing side effects.

Targeted radionuclide therapy shows promise for improving head and neck cancer treatment but needs more research.

Tofacitinib and baricitinib had an acceptable level of side effects in rheumatoid arthritis patients.

Anxiety and depression were present but didn't affect overall quality of life in breast cancer patients on chemotherapy.

Experts agree on how to manage sugar levels and skin reactions in patients taking the cancer drug alpelisib.

Combining immune checkpoint inhibitors with other cancer therapies increases skin side effects in Asian patients.

The (+) enantiomer of YH239-EE effectively kills breast cancer cells.

Some chemotherapy can cause permanent hair loss.

Women with PCOS-related infertility can often conceive with treatments like clomiphene and metformin, but managing pregnancy complications is important.